A Hematology Fellowship Journey in the “Golden Age” of Cancer Research

Written by

in

RWJBarnabas Health hematology fellow Matthew Karr, DO, describes his career path and outlines research interests in diseases such as CLL and CNS lymphoma. Karr focuses on novel triplet therapies, time-limited or continuous treatment options, in vivo CAR T cells, p53 reactivation, and bispecific antibodies for CNS lymphoma. He also explores how to evaluate AI-generated answers related to leukemia.

Source:CancerNetwork · Read Original

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *